Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APO-PERPHENAZINE TABLET 8 mg - HSA Drug Approval Details

Approvals/HSA/APO-PERPHENAZINE TABLET 8 mg

Approved

THERAPEUTIC

APO-PERPHENAZINE TABLET 8 mg

APOTEX INC (CANADA)🇸🇬 Health Sciences Authority

Approval Date: Apr 27, 1988
Approval ID: fb1259fd11b3a6e2
Company: APOTEX INC (CANADA)
Type: Therapeutic

Approval Details

Approval Id: fb1259fd11b3a6e2
Drug Name: APO-PERPHENAZINE TABLET 8 mg
Product Name: APO-PERPHENAZINE TABLET 8 mg
Approval Number: SIN00437P
Approval Date: 1988-04-27
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: N05AB03
Atc Item Name: perphenazine
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

PERPHENAZINE

8 mg

PERPHENAZINE

8 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 27, 1988

Approval ID

fb1259fd11b3a6e2

Type

Therapeutic

Back to HSA Approvals